NBI On Drugs
You won’t recognize the Nasdaq Biotechnology Index (NBI) the next time you see it. It’s undergone a radical change, bulking up to nearly twice its original size by adding 55 more companies to the list. The new Index, which debuted November 24, now consists of 129 firms – and many of the new additions are drug companies (including specialty pharmas and generic drug manufacturers).
Archive for November, 2003

106986505626764318
November 26, 2003
106971382395124559
November 24, 2003Glowing red GM fish to sell in US
A tropical fish that fluoresces bright red is set to become the first genetically modified pet to go on sale in the US. Alan Blake and colleagues at Yorktown Technologies LP say the GloFish will be available from January 2004.

106970157748547355
November 24, 2003Slowdown casts doubt on biotech offerings
After a two-year capital drought, seven biotechnology and life sciences companies made initial public offerings in October and early this month. Now the newly issued stock of six of those companies is underwater — and one, Acusphere Inc. of Watertown, has lost 50 percent of its value since going public…

106968861316822531
November 24, 2003Machine Could Sequence Human Genome in a Year
A new gene-reading machine is so much faster than existing technology that it could sequence the human genome in a year while it took more than 10 years the first time around.

106925865872218526
November 19, 2003Biotech Raises More Cash in 2003 But Europe Weak
The global biotechnology industry raised more money by the end of September than in the whole of 2002 but a revival in Europe, which remains weak, could be more than six months away, industry analysts said on Tuesday.

106918287823279006
November 18, 2003Is That Daylight for ImClone?
The beleaguered drugmaker finally gets some good news with Swiss approval of its cancer-fighting drug Erbitux

106917585461473489
November 18, 2003Over the Rainbow Yet?
Consolidation slows, valuations grow, and now hope for some IPOs

106917164488928425
November 18, 2003Ultimate Analysis
With the necessary tools at hand, the race is on to build — and market — the first affordable, portable, fully functional DNA analyzer. Is the world ready?

106908389597110728
November 17, 2003COUNTERING COUNTERFEITS
Industry offers proposals to fight growing problem of fake drugs.

106908381962467013
November 17, 2003BAYER CHEMICALS TO TAKE A SPIN
Split-off of chemicals will shift firm’s focus to life sciences
